EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao, Christine Thumann, Isabel Fofana, Laetitia Zona, Christopher Davis, Christopher J. Mee, Marine Turek, Sebastian Gorke, Cathy Royer, Benoit Fischer, Muhammad N. Zahid, Dimitri Lavillette, Judith Fresquet, Francois-Loic Cosset, S. Michael Rothenberg, Thomas Pietschmann, Arvind H. Patel, Patrick PessauxMichel Doffoel, Wolfgang Raffelsberger, Olivier Poch, Jane A. McKeating, Laurent Brino, T.F. Baumert

    Research output: Contribution to journalArticle

    479 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)589-595
    JournalNature Medicine
    Volume17
    Issue number5
    DOIs
    Publication statusPublished - 24 Apr 2011

    Cite this

    Lupberger, J., Zeisel, M. B., Xiao, F., Thumann, C., Fofana, I., Zona, L., ... Baumert, T. F. (2011). EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nature Medicine, 17(5), 589-595. https://doi.org/10.1038/nm.2341